Growth deceleration in children treated with imatinib for chronic myeloid leukaemia-Reference-Cited by-同舟云学术

Growth deceleration in children treated with imatinib for chronic myeloid leukaemia

Published:2014-12 Issue:18 Volume:50 Page:3206-3211
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Millot Frédéric,Guilhot Joelle,Baruchel André,Petit Arnaud,Leblanc Thierry,Bertrand Yves,Mazingue Françoise,Lutz Patrick,Vérité Cecile,Berthou Christian,Galambrun Claire,Sirvent Nicolas,Yacouben Karima,Chastagner Pascal,Gandemer Virginie,Reguerre Yves,Couillault Gérard,Khalifeh Tackwa,Rialland Fanny

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. Leukemias;Smith,1999

2. Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial;Millot;J Clin Oncol,2011

3. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2007

4. International Randomized Study of Interferon Versus STI571 (IRIS) 7-Year Follow-up: Sustained Survival, Low Rate of Transformation and Increased Rate of Major Molecular Response (MMR) in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CMLCP) Treated with Imatinib (IM)

5. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors;Buchdunger;J Pharmacol Exp Ther,2000

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Tyrosine Kinase Inhibitors (TKIs) on Growth in Children and Adolescents with Chronic Myeloid Leukemia: A Systematic Review;Current Pharmaceutical Design;2024-09

2. Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group;British Journal of Haematology;2024-05-27

3. How I treat long-term survivors of childhood acute leukemia;Blood;2024-05-02

4. Male Fertility and Fatherhood in Chronic Myeloid Leukemia: Current Understanding and Future Perspectives;Cancers;2024-02-15

5. Therapeutic drug monitoring of imatinib – how far are we in the leukemia setting?;Expert Review of Clinical Pharmacology;2024-02-12